Goldman Sachs Group Inc Delcath Systems, Inc. Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 39,062 shares of DCTH stock, worth $404,682. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,062Holding current value
$404,682% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DCTH
# of Institutions
62Shares Held
7.93MCall Options Held
118KPut Options Held
69.9K-
Aigh Capital Management LLC Baltimore, MD2.4MShares$24.9 Million7.28% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.67MShares$17.3 Million2.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$10.3 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA337KShares$3.49 Million0.57% of portfolio
-
Geode Capital Management, LLC Boston, MA245KShares$2.53 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $89.1M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...